Key Points
The presence of ≥3 large focal lesions is associated with poor outcome in newly diagnosed myeloma patients.
The prognostic impact of multiple large focal lesions is independent of R-ISS, GEP70, and extramedullary disease.
Visual Abstract
Abstract
Spatial intratumor heterogeneity is frequently seen in multiple myeloma (MM) and poses a significant challenge for risk classifiers, which rely on tumor samples from the iliac crest. Because biopsy-based assessment of multiple skeletal sites is difficult, alternative strategies for risk stratification are required. Recently, the size of focal lesions (FLs) was shown to be a surrogate marker for spatial heterogeneity, suggesting that data from medical imaging could be used to improve risk stratification approaches. Here, we investigated the prognostic value of FL size in 404 transplant-eligible, newly diagnosed MM patients. Using diffusion-weighted magnetic resonance imaging with background suppression, we identified the presence of multiple large FLs as a strong prognostic factor. Patients with at least 3 large FLs with a product of the perpendicular diameters >5 cm2 were associated with poor progression-free survival (PFS) and overall survival (OS; median, 2.3 and 3.6 years, respectively). This pattern, seen in 13.8% of patients, was independent of the Revised International Staging System (RISS), gene expression profiling (GEP)–based risk score, gain(1q), or extramedullary disease (hazard ratio, 2.7 and 2.2 for PFS and OS in multivariate analysis, respectively). The number of FLs lost its negative impact on outcome after adjusting for FL size. In conclusion, the presence of at least 3 large FL is a feature of high risk, which can be used to refine the diagnosis of this type of disease behavior and as an entry criterion for risk-stratified trials.
- Submitted April 2, 2018.
- Accepted May 10, 2018.
- © 2018 by The American Society of Hematology
To view this item, select one of the options below.
ASH Members and Subscribers
If you already have a subscription, you may gain access using your ASH username and password.
Purchase Short-Term Access
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$75.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
OpenAthens Users
Log in through your institution
Sign Up
Subscribe to the Journal - Subscribe to the print and/or online journal.